Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Incompetent CEO

<< Previous

Bullboard Posts

Next >>

Comment by Layth1990on Mar 05, 2021 1:20pm

142 Views

Post# 32729456

RE:RE:RE:Incompetent CEO

Do you know why they will do it before phase 3. Remember my words, the deal will be high and they will load tons of shares due to ate low sp. if they do it after the ate sp will be high. Dan and wallace are highest holders at ate holding.

not to mention the buy volume before nuance deal. Leaked news ? Or more like dan and wallce family are buying and dumped after! I have zero trust in those 2 anymore. Everything is excuted for their own good

<< Previous

Bullboard Posts

Next >>

Victoria Gold stock falls 82% after Yukon landslide halts production